AARX Weight Loss Jacksonville

AARX Weight Loss Jacksonville operates as a telehealth medical weight loss clinic serving patients throughout Florida under the medical direction of Dr. Dawn Ericsson. The practice focuses exclusively on physician-supervised weight management programs utilizing GLP-1 receptor agonist medications, specifically semaglutide and tirzepatide, combined with structured nutritional guidance and accountability coaching. As a LegitScript certified provider and member of the American Academy of Anti-Aging Medicine, AARX Weight Loss Jacksonville adheres to verified standards for telemedicine prescribing and patient safety protocols in the medical weight loss sector.

The clinic's treatment protocols center on two FDA-approved peptide medications: semaglutide, which mimics the GLP-1 hormone to regulate appetite and glucose metabolism, and tirzepatide, a dual GIP/GLP-1 receptor agonist that targets multiple pathways involved in weight regulation. Dr. Ericsson prescribes these medications following comprehensive intake assessments that include medical history review, current medication evaluation, and contraindication screening. Patients receive individualized dosing schedules that typically begin with lower doses and titrate upward based on tolerance and response, following established clinical protocols for these peptide therapies. The Jacksonville-based program ships medications directly to patients' homes throughout Florida, with dosing instructions and injection technique guidance provided during virtual consultations.

Dr. Dawn Ericsson brings board-certified medical expertise to the practice's weight loss programs, with additional certification through the American Medical Management Group (AMMG), which specializes in obesity medicine and metabolic health training. Her approach integrates peptide therapy with behavioral modification strategies, requiring patients to participate in regular coaching sessions that address eating patterns, physical activity integration, and weight maintenance planning. The clinic's accredited business status reflects compliance with operational standards in the telemedicine weight loss industry, while AMMG certification indicates specialized training in medical weight management beyond standard medical education.

Patients enrolling in AARX Weight Loss Jacksonville programs complete an initial virtual consultation with Dr. Ericsson or her medical team, during which eligibility for GLP-1 therapy is determined based on BMI criteria, medical history, and treatment goals. The program includes monthly medication refills coordinated with follow-up telehealth appointments to monitor progress, adjust dosing, and address side effects such as nausea or gastrointestinal changes common with these peptide medications. Coaching sessions occur separately from medical visits, providing patients with meal planning resources, portion control strategies, and accountability check-ins. The clinic does not require patients to purchase proprietary meal replacements or supplements, instead focusing on sustainable dietary modifications that patients can maintain long-term.

As a Florida-based telehealth provider, AARX Weight Loss Jacksonville eliminates the need for in-person clinic visits, allowing patients throughout the state to access physician-supervised peptide therapy without geographic limitations. The practice maintains transparent pricing structures published on its website, with program costs covering medical consultations, peptide medications, and coaching services in bundled monthly fees. Dr. Ericsson's team coordinates laboratory work through local facilities when baseline metabolic panels or thyroid function tests are clinically indicated before initiating treatment. The clinic's membership in the American Academy of Anti-Aging Medicine reflects its focus on metabolic optimization and age-related weight management, addressing how hormonal changes and metabolic slowdown contribute to weight gain in adult patients seeking medical intervention beyond diet and exercise alone.